
1. biotechnol bioeng. 2017 jan;114(1):163-171. doi: 10.1002/bit.26048. epub 2016 jul
28.

toward "homolactic" fermentation glucose xylose engineered
saccharomyces cerevisiae harboring kinetically efficient l-lactate
dehydrogenase within pdc1-pdc5 deletion background.

novy v(1), brunner b(1), müller g(1), nidetzky b(1)(2).

author information: 
(1)graz university technology, institute biotechnology biochemical
engineering, nawi graz, petersgasse 12/i, 8010 graz, austria.
(2)austrian centre industrial biotechnology, graz, austria.

l-lactic acid important platform chemical production the
lignocellulosic sugars glucose xylose is, therefore, high interest.
tolerance low ph generally high robustness make saccharomyces cerevisiae
a promising host l-lactic acid fermentation strain development for
effective utilization sugars unsolved problem. herein used s.
cerevisiae strain ibb10b05 incorporates nadh-dependent pathway for
oxidoreductive xylose assimilation within cen.pk113-7d background was
additionally evolved accelerated xylose-to-ethanol fermentation. selecting
the plasmodium falciparum l-lactate dehydrogenase (pfldh) high kinetic
efficiency, strain ibb14la1 derived ibb10b05 placing pfldh gene
at pdc1 locus control pdc1 promotor. strain ibb14la1_5
additionally pdc5 gene disrupted. strains, continued l-lactic
acid formation glucose xylose, 50 g/l, necessitated stabilization
of ph. using calcium carbonate (11 g/l), anaerobic shaken bottle fermentations at
ph ≥ 5 resulted l-lactic acid yields (yla ) 0.67 g/g glucose 0.80 g/g
xylose strain ibb14la1_5. little xylitol formed (≤0.08 g/g) no
ethanol. ph stabilized aerobic conversions glucose, strain ibb14la1_5
further showed excellent l-lactic acid productivities (1.8 g/l/h) without losses 
in yla (0.69 g/g glucose). strain ibb14la1, yla lower (≤0.18 g/g
glucose; ≤0.27 g/g xylose) due ethanol well xylitol formation.
therefore, study shows s. cerevisiae strain originally optimized 
xylose-to-ethanol fermentation useful implement l-lactic acid production
from glucose xylose; metabolic engineering strategy applied,
advance toward homolactic fermentation sugars made. biotechnol.
bioeng. 2017;114: 163-171. © 2016 wiley periodicals, inc.

© 2016 wiley periodicals, inc.

doi: 10.1002/bit.26048 
pmid: 27426989  [indexed medline]

